Home
Board of Directors

Hogerkorp

4th June 2020Malin Bergholm

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Save my name and email in this browser for the next time I comment.

Recent Posts

New discoveries in cancer related immunosuppression are paving the way for an entirely new immunotherapeutic strategy.
CanImGuide Initiates Clinical Development of New Treatment in Cancer
The Nobel Prize in Medicine puts the spotlight on CanImGuide’s focus area Immunology.
CanImGuide appoints new CEO

What we do

CanImGuide is a company with a novel, simple but sophisticated and highly innovative, peptide approach to immuno-oncology.

CanImGuide Therapeutics AB Scheelevägen 2, 223 81 Lund, Sweden

info@dev.canimguide.com

© 2021 All rights reserved. CanimGuide Therapeutics AB

Menu